General Biotechnology

Stop Patent Hops: Detecting “Evergreening” Patterns Through Sequential FDA Orange Book Listings

Evergreen patents aren’t “new” inventions—they’re often new paperwork.
That’s the core warning in a recent DrugPatentWatch post on how companies can extend exclusivity by exploiting the FDA’s Orange Book mechanics—specifically through sequential listin…

Stop Patent Hops: Detecting “Evergreening” Patterns Through Sequential FDA Orange Book Listings Read Post »

Biotechblog
Scroll to Top